Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 46,532 shares at $20.04 ($936K) on 2016-09-21, disclosed to the SEC on 2016-09-23.
Open-market sale of $936k BLCM by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.04 | 100 | $2K | 0.2% |
| 2 | $20.11 | 11,958 | $240K | 25.7% |
| 3 | $20.11 | 11,958 | $241K | 25.7% |
| 4 | $20.12 | 11,258 | $227K | 24.2% |
| 5 | $20.12 | 11,258 | $227K | 24.2% |
| Total | $20.12 avg | 46,532 |
| $936K |
| 100% |
| Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $2.0M | — | Filing → |
| BLCM | SELL | 2016-07-29 | $225K | — | Filing → |